Causal Association Between Plasma Vascular Endothelial Growth Factor Family Proteins and Placenta Previa: A Two-Sample Mendelian Randomization Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 207,473
- 主要终点
- Causal relationship between plasma VEGFA levels and the risk of placenta previa
研究概览
简要总结
This study aims to investigate the causal relationship between plasma vascular endothelial growth factor (VEGF) family proteins and placenta previa using a two-sample Mendelian randomization (MR) approach. Genome-wide association study (GWAS) data will be analyzed to assess the correlation and potential causality between VEGF protein levels and the occurrence of placenta previa.
详细描述
Placenta previa is a serious complication during pregnancy, leading to significant risks for both the mother and the fetus. This study utilizes Mendelian randomization (MR) to explore the potential causal link between plasma levels of VEGF family proteins (including VEGFA, VEGFB, VEGFC, VEGFD, and PLGF) and the risk of placenta previa. By using genome-wide association study (GWAS) data from the UK Biobank and FinnGen datasets, the study aims to provide insights into the role of angiogenesis and abnormal placental development. The MR analysis will help minimize confounding factors and provide robust evidence regarding the causal relationship between VEGF proteins and placenta previa.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants included in genome-wide association studies (GWAS) with available data on plasma VEGF family proteins and placenta previa.
排除标准
- •Participants with incomplete or missing data on plasma VEGF levels or placenta previa.
结局指标
主要结局
Causal relationship between plasma VEGFA levels and the risk of placenta previa
时间窗: Data analysis and outcome assessment will be completed by December 2024
This outcome measures the association between plasma VEGFA levels (measured in picograms per milliliter) and the occurrence of placenta previa, using Mendelian Randomization (MR) analysis to assess causality.
次要结局
- Causal relationship between plasma PLGF levels and the risk of placenta previa(Data analysis and outcome assessment will be completed by December 2024)
- Causal relationship between plasma VEGFB levels and the risk of placenta previa(Data analysis and outcome assessment will be completed by December 2024)
- Causal relationship between plasma VEGFC levels and the risk of placenta previa(Data analysis and outcome assessment will be completed by December 2024)
研究者
Zhibin Xu
Professor
Guangzhou Institute of Respiratory Disease
